Overview

Study Comparing Tapinarof Cream 1% To VTAMA (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-11-28

Target enrollment:

Participant gender:

Summary

To compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.

Phase:

PHASE3

Details

Lead Sponsor:

Teva Pharmaceuticals USA

Collaborator:

Teva Pharmaceuticals, Inc.